Health

National recall issued on blood pressure medication

Two blood pressure medications have been recalled for high levels of impurity.

The United States Food and Drug Administration sent out an announcement of a recall last week for batches of blood pressure medication from Lupin Pharmaceuticals Inc. The batches of Irbesartan Tablets and Irbesartan and Hydrochlorothiazide had high levels of the impurity N-nitrosoirbesartan found.

N-nitrosoirbesartan impurity is considered a possible carcinogen, according to the FDA. While no deaths resulted from the impurity, there were four cases of illness reported between Oct. 8, 2018 and Sept. 30, 2021. Oct. 8, 2-18 was the earliest date of distribution for these batches. These illnesses were in response only to the Irbesartan Tablets.

“Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, drug chains, mail order pharmacies and supermarkets by phone and through recall notification and is arranging for the return of all the recalled product lots,” the FDA stated in its announcement.

Lupin Pharmaceuticals discontinued the marketing of these products on Jan. 7 of this year.

If you are taking the recalled medication, the FDA advises that you continue to do so, but contact your physician and consider alternative treatment.

Any reactions or quality issues can be reported to FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

For a full list of the batches affected or to report reactions online, visit FDA.gov.

Written by Chris Carr

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s